Ever since the meeting concluded, the Hua University Physics Department had been pressured by both the Psychology Society and the Society of Mental Disorders to accommodate Gu Yang. Eventually, they relented, allowing her to enroll in multiple courses.
Given Gu Yang's advanced expertise, surpassing even some professors, she was permitted to accelerate through her studies and skip classes. Upon passing assessments, she could directly earn her degree.
After three treatment sessions, Gu Yang visited the Yangning Research Institute for a check-up, where it was confirmed that her hemophilia had been completely cured.
Simultaneously, the hemophilia medication developed by the Yangning Research Institute underwent rigorous review processes and gained approval for listing.
The Yangning Research Institute team focused on scientific research, while Good Pharmaceuticals, under Gu Jin's management, handled the pharmaceutical sales.
